Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Nice finish with chunk of 0.24s taken out

<< Previous

Bullboard Posts

Next >>

Comment by newdaydawningon Sep 07, 2021 7:18pm

290 Views

Post# 33823001

RE:Nice finish with chunk of 0.24s taken out

A multi-billion dollar valuation is in the cards here once FDA approves TLD-1433 for NMIBC, the anti-viral tackles all Covid variations, ph 1 of GBM and LUNG begin.

Assuming 250M shares fully diluted after exercise of 35-cent warrants, the lowest possible price starts at $8.00 per share.